Page values for "Torsemide"
From Pharmacopedia
More actions
"Medicines" values
1 row is stored for this page| Field | Field type | Value |
|---|---|---|
| generic | String | Torsemide |
| brand | String | Demadex, Soaanz |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:Loop_diuretics|Loop diuretic]] |
| mechanism | String | '"`UNIQ--vote-00000B40-QINU`"' The TRANSFORM-HF trial (2023) found no all-cause mortality difference between torsemide and furosemide in heart failure, although torsemide remains pharmacologically preferred where furosemide oral absorption is unreliable'"`UNIQ--ref-00000B41-QINU`"'. |
| uses | String | '"`UNIQ--vote-00000B42-QINU`"', '"`UNIQ--vote-00000B43-QINU`"', '"`UNIQ--vote-00000B44-QINU`"', '"`UNIQ--vote-00000B45-QINU`"' |
| starting_dose | String | 10-20 mg PO/IV once daily; titrate by clinical response. 1:1 IV to PO conversion (unlike furosemide's 1:2) |
| preparations | String | 5, 10, 20, 100 mg tablets; 10 mg/mL IV |
| fda_max | String | 200 mg/d typical practical ceiling |
| pill_id | Text | |
| routes | List of String, delimiter: , | Oral • IV |
| onset | String | PO 1 hour; IV 10 minutes |
| duration | String | 6-8 hours |
| halflife | String | 3-4 hours (similar between PO and IV due to high oral bioavailability)'"`UNIQ--ref-00000B46-QINU`"' |
| bioavailability | String | ~80% (oral; predictable absorption — a substantive practical advantage over furosemide whose oral absorption is 10-100% variable)'"`UNIQ--ref-00000B47-QINU`"' |
| pregnancy | String | Avoid where possible; class concerns as for other loop diuretics.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> |
| legal | String | [[USLegal:Prescription only|Rx-only]] in US |